Similar articles

• Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?

  Sibaud V, Delord JP, Chevreau C. Sibaud V, et al. Target Oncol. 2009 Dec;4(4):307-10. doi: 10.1007/s11523-009-0127-8. Epub 2009 Nov 7. Target Oncol. 2009. PMID: 19894099
• Interstitial granulomatous drug reaction to sorafenib.

  Martínez-Morán C, Nájera L, Ruiz-Casado AI, Romero-Maté A, Espinosa P, Meseguer-Yebra C, Córdoba S, Borbujo JM. Martínez-Morán C, et al. Arch Dermatol. 2011 Sep;147(9):1118-9. doi: 10.1001/archdermatol.2011.241. Arch Dermatol. 2011. PMID: 21931061 No abstract available.
• [Hand-foot syndrome and sorafenib].

  Milano G, Mortier L, Digue L, Desmedt E, Ravaud A. Milano G, et al. Bull Cancer. 2009 Feb;96(2):191-7. doi: 10.1684/bdc.2008.0814. Bull Cancer. 2009. PMID: 19258226 French.
• [Hand-foot syndrome after administration of tyrosinkinase inhibitors].

  Bednaríková D, Kocák I. Bednaríková D, et al. Klin Onkol. 2010;23(5):300-5. Klin Onkol. 2010. PMID: 21061680 Review. Czech.
• Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.

  McLellan B, Kerr H. McLellan B, et al. Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x. Dermatol Ther. 2011. PMID: 21910797 Review.